查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
HLA 分型市場規模、份額、趨勢分析報告：按產品（試劑/耗材、軟件/服務）、技術、應用（診斷、研究）、最終用戶、地區、細分市場，2023-2030 年
市場調查報告書
商品編碼
1171082

HLA 分型市場規模、份額、趨勢分析報告：按產品（試劑/耗材、軟件/服務）、技術、應用（診斷、研究）、最終用戶、地區、細分市場，2023-2030 年

HLA Typing Market Size, Share & Trends Analysis Report By Product (Reagents & Consumables, Software & Services), By Technique, By Application (Diagnosis, Research), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

HLA 分型市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，HLA 分型的全球市場預計到 2030 年將達到 17 億美元。 從 2023 年到 2030 年，該市場預計將以 6.7% 的複合年增長率增長。 幹細胞移植的興起以及人類白細胞抗原 (HLA) 分型在其他應用中的廣泛使用預計將支持市場增長。 從 2016 年到 2020 年，美國大約進行了 111,984 例造血細胞移植，其中 89% 的細胞來源來自外周血，9% 來自骨髓，2% 來自臍帶血。 同樣，該地區擁有超過 219 個進行造血細胞移植的設施。

HLA 分型有望成為各種基礎和轉化研究的寶貴資源。 這是因為某些 HLA 等位基因會影響嚴重程度和對感染的易感性，而其他等位基因則與自身免疫性疾病和癌症等疾病的多種遺傳易感性有關。 . 深入了解哪些單倍型更有可能發展為嚴重疾病或預後較差，這對於藥物開發的轉化應用特別有用。 因此，預計將 HLA 分型用於研究應用將對整體市場估計做出重大貢獻。

COVID-19 大流行對市場產生了負面影響。 少數研究人員提出了將 HLA 分型與 COVID-19 檢測相結合的概念。 例如，2021 年 8 月，發表在《歐洲醫學研究雜誌》上的一項研究的科學證據表明，臨床試驗應包括 HLA 結合，並將其與 COVID-19 檢測相結合，以加快識別人群中的預測因子。

預計公司不斷增加的戰略舉措將推動市場的增長。 例如，2022年3月，Immucor, Inc.宣布推出HLA分型軟件，作為HLA分型檢測的配套產品。 該軟件有望成為用戶節省成本的選擇，並使 NGS 分析過程更加輕鬆快捷。

另一方面，越來越多的受者被從器官移植等候名單中剔除，將影響HLA分型的利用。 從名單中刪除的原因包括患者病情惡化、患者死亡和疾病康復。 例如，從2021年1月到2021年12月，巴恩斯猶太醫院有6名患者死於器官短缺，11名患者病情惡化。

HLA 打字市場報告要點

按產品劃分，預計試劑耗材部分將在預測期內實現最快的增長率。 現有參與者的產品開發正在加緊進行，以擴大 HLA 分型在免疫治療等各個研究領域的應用。

從應用來看，診斷領域有望在2022年呈現出最快的增長速度，並佔據更大的份額。 它已被證明是器官移植和傳染病上升的重要信息來源，從而促進了市場的增長。

就技術而言，基於測序的分子檢測部分預計在 2023 年至 2030 年期間的複合年增長率最快。 這是因為它在單個測定中提供了明確的相分離 HLA 分型。

按最終用戶劃分，醫院和移植中心部分預計將在 2022 年佔據大部分市場份額。 這是因為發達國家擁有裝備精良的研究設施

北美以 46.94% 的總市場份額鞏固了其區域地位。 這是由於移植中心和診所的存在，以及該地區主要參與者的存在。

內容

第一章研究方法論

  • 按國家/地區劃分的市場：基本估計
  • 全球市場：CAGR 計算
  • 按地區計算細分市場份額
  • 調查範圍和假設
  • 數據源列表
    • 來自主要訪談的數據（按來源）
    • 按地區劃分的首次訪談數據

第 2 章執行摘要

  • 市場概況

第 3 章 HLA 分型市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場驅動因素分析
    • 增加器官移植
    • 測試技術的技術進步
    • 在藥物遺傳學中採用 HLA 檢測
  • 市場製約因素分析
    • 嚴格的監管框架
  • HLA 分類 - SWOT 分析，按因素（政治和法律、經濟、技術）
  • 行業分析 - 搬運工
  • HLA 打字市場：2022 年市場分析
  • COVID-19 影響分析

第 4 章 HLA 分型市場：按產品分類的估計和趨勢分析

  • HLA 分型市場：按產品分類的變化分析
  • 儀器
    • 樂器市場
  • 試劑和耗材
    • 試劑和耗材市場
  • 軟件和服務
    • 軟件和服務市場

第 5 章 HLA 分型市場：應用的估計和趨勢分析

  • HLA 分型市場：按應用進行的變化分析
  • 診斷
    • 診斷市場
  • 調查
    • 研究市場

第 6 章 HLA 分型市場：按技術估算和趨勢分析

  • HLA 分型市場：技術變化分析
  • 分子檢測
    • 分子檢測市場
  • 基於序列的分子檢測
    • 基於序列的分子檢測市場
  • 非分子檢測
    • 非分子檢測市場

第 7 章 HLA 分型市場：最終用戶的估計和趨勢分析

  • HLA 打字市場：最終用戶的變化分析
  • 商業服務提供商
    • 商業服務提供商市場
  • 醫院和移植中心
    • 醫院和移植中心市場
  • 研究和學術機構
    • 研究和學術機構市場

第 8 章 HLA 分型市場：按產品、應用、技術和最終用途分類的區域估計和趨勢分析

  • 2022 年和 2030 年各地區 HLA 分型市場份額
  • 北美
    • SWOT 分析
      • 2022 年和 2030 年按產品分列的北美 HLA 分型市場份額
      • 北美 HLA 分型市場，按應用分類
      • 北美 HLA 分型市場，按最終用戶分類
      • 北美 HLA 分型市場，按技術分類
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 美國 HLA 分型市場，按產品分類
      • 美國 HLA 分型市場，按應用分類
      • 美國 HLA 分型市場，按最終用戶分類
      • 美國 HLA 分型市場，按技術分類
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 加拿大 HLA 分型市場，按產品分類
      • 加拿大 HLA 分型市場，按應用分類
      • 加拿大 HLA 分型市場，按最終用戶分類
      • 加拿大 HLA 分型市場，按技術分類
  • 歐洲
    • SWOT 分析
      • 歐洲 HLA 分型市場，按產品分類
      • 歐洲 HLA 分型市場，按應用分類
      • 歐洲 HLA 分型市場，按最終用戶分類
      • 歐洲 HLA 分型市場，按技術分類
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 德國 HLA 分型市場，按產品分類
      • 德國 HLA 分型市場，按應用分類
      • 德國 HLA 類型市場，按最終用戶分類
      • 德國 HLA 分型市場，按技術分類
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 英國 HLA 分型市場，按產品分類
      • 英國 HLA 分型市場，按應用分類
      • 英國 HLA 打字市場，按最終用戶分類
      • 英國 HLA 分型市場，按技術分類
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 法國 HLA 分型市場，按產品
      • 法國 HLA 分型市場，按應用分類
      • 法國 HLA 分型市場，按最終用戶分類
      • 法國 HLA 分型市場，按技術分類
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 意大利 HLA 分型市場，按產品分類
      • 意大利 HLA 分型市場，按應用分類
      • 意大利 HLA 打字市場，按最終用戶分類
      • 意大利 HLA 分型市場，按技術分類
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 西班牙 HLA 分型市場，按產品分類
      • 西班牙 HLA 分型市場，按應用分類
      • 西班牙 HLA 打字市場，按最終用戶分類
      • 西班牙 HLA 分型市場，按技術分類
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 丹麥 HLA 分型市場，按產品
      • 丹麥 HLA 分型市場，按應用分類
      • 丹麥 HLA 打字市場，按最終用戶分類
      • 丹麥 HLA 分型市場，按技術分類
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 瑞典 HLA 分型市場，按產品分類
      • 瑞典 HLA 分型市場，按應用分類
      • 瑞典 HLA 分型市場，按最終用戶分類
      • 瑞典 HLA 分型市場，按技術分類
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 挪威 HLA 分型市場，按產品分類
      • 挪威 HLA 分型市場，按應用分類
      • 挪威 HLA 打字市場，按最終用戶分類
      • 挪威 HLA 分型市場，按技術分類
  • 亞太地區
    • SWOT 分析
      • 亞太地區 HLA 分型市場，按產品分類
      • 亞太地區 HLA 分型市場，按應用分類
      • 亞太地區 HLA 打字市場，按最終用戶分類
      • 亞太地區 HLA 分型市場，按技術分類
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 日本 HLA 分型市場，按產品
      • 日本 HLA 分型市場，按應用分類
      • 日本 HLA 分型市場，按最終用戶分類
      • 日本 HLA 分型市場，按技術分類
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 中國 HLA 分型市場，按產品分類
      • 中國 HLA 分型市場，按應用分類
      • 中國 HLA 分型市場，按最終用戶分類
      • 中國的 HLA 分型市場，按技術分類
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 印度 HLA 分型市場，按產品分類
      • 印度 HLA 分型市場，按應用分類
      • 印度 HLA 分型市場，按最終用戶分類
      • 印度 HLA 分型市場，按技術分類
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 韓國 HLA 分型市場，按產品分類
      • 韓國 HLA 分型市場，按應用分類
      • 韓國 HLA 打字市場，按最終用戶分類
      • 韓國 HLA 分型市場，按技術分類
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 澳大利亞 HLA 分型市場，按產品分類
      • 澳大利亞 HLA 分型市場，按應用分類
      • 澳大利亞 HLA 分型市場，按最終用戶分類
      • 澳大利亞 HLA 分型市場，按技術分類
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 泰國 HLA 分型市場，按產品
      • 泰國的 HLA 分型市場，按應用分類
      • 泰國 HLA 打字市場，按最終用戶分類
      • 泰國 HLA 分型市場，按技術分類
  • 拉丁美洲
    • SWOT 分析
      • 拉丁美洲 HLA 分型市場，副產品
      • 拉丁美洲 HLA 分型市場，按應用分類
      • 拉丁美洲 HLA 類型市場，按最終用戶分類
      • 拉丁美洲 HLA 分型市場，按技術分類
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 巴西 HLA 分型市場，副產品
      • 巴西 HLA 分型市場，按應用分類
      • 巴西 HLA 打字市場，按最終用戶分類
      • 巴西 HLA 分型市場，按技術分類
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 墨西哥 HLA 分型市場，按產品分類
      • 墨西哥 HLA 分型市場，按應用分類
      • 墨西哥 HLA 打字市場，按最終用戶分類
      • 墨西哥 HLA 分型市場，按技術分類
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 阿根廷 HLA 分型市場，按產品分類
      • 阿根廷 HLA 分型市場，按應用分類
      • 阿根廷 HLA 打字市場，按最終用戶分類
      • 阿根廷 HLA 分型市場，按技術分類
  • 多邊環境協定
    • SWOT 分析
      • MEA HLA 分型市場，按產品分類
      • MEA HLA 分型市場，按應用分類
      • MEA HLA 打字市場，按最終用戶分類
      • MEA HLA 分型市場，按技術分類
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 南非 HLA 分型市場，按產品分類
      • 南非 HLA 分型市場，按應用分類
      • 南非 HLA 分型市場，按最終用戶分類
      • 南非 HLA 分型市場，按技術分類
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 沙特阿拉伯 HLA 分型市場，副產品
      • 沙特阿拉伯 HLA 分型市場，按應用分類
      • 沙特阿拉伯 HLA 打字市場，按最終用戶分類
      • 沙特阿拉伯 HLA 分型市場，按技術分類
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 阿拉伯聯合酋長國 HLA 分型市場，按產品分類
      • 阿拉伯聯合酋長國 HLA 分型市場，按應用分類
      • 阿拉伯聯合酋長國 HLA 打字市場，按最終用戶分類
      • 阿拉伯聯合酋長國 HLA 分型市場，按技術分類
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
      • 科威特 HLA 分型市場，副產品
      • 科威特 HLA 分型市場，按應用分類
      • 科威特 HLA 打字市場，按最終用戶分類
      • 科威特 HLA 分型市場，按技術分類

第9章競爭格局

  • Participant's overview
  • Financial performance
  • 參與者分類
    • 市場領導者
      • 2022 年 HLA 打字市場份額分析
      • 公司簡介
      • Thermo Fisher Scientific Inc.
      • Bio-Rad Laboratories Inc.
      • Qiagen N.V.
      • Omixon Inc.
      • GenDx
      • Illumina Inc.
      • TBG Diagnostics Limited
      • Dickinson and Company
      • Takara Bio Inc.
      • F. Hoffman-La Roche Limited
      • Pacific Biosciences
    • 戰略規劃
      • 分機
      • 得到
      • 協作
      • 產品/服務發布
      • 夥伴關係
      • 其他
Product Code: GVR-4-68040-007-6

HLA Typing Market Growth & Trends:

The global HLA typing market size is expected to reach USD 1.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2023 to 2030. The increasing stem cell transplantation coupled with expanding the use of human leukocyte antigen (HLA) typing in other applications is expected to support the growth of the market. From 2016 to 2020, around 111,984 hematopoietic cell transplantations were performed in the U.S. Out of those, 89% of cell sources were peripheral blood, 9% were from bone marrow and 2% were from cord blood. Similarly, there are over 219 centers in the region for performing hematopoietic cell transplantations.

HLA typing is expected to be a valuable source of information for various basic and translational research studies. Since some HLA alleles can impact the severity and susceptibility of infectious diseases, while other HLA alleles are related to the diverse predispositions of genetics to diseases such as autoimmune conditions and cancer. Gaining insights into which haplotypes can have a higher probability of critical disease or poor prognosis can be specifically useful in translational applications for developing therapeutics. Hence, HLA typing usage in research applications is expected to have a considerable contribution to the overall market estimates.

The COVID-19 pandemic adversely impacted the market. Although there was a handful of researchers with the concept of integrating HLA typing with COVID-19 testing. For instance, in August 2021, the scientific evidence from research published in the European Journal of Medical Research suggested including HLA tying in clinical trials and combining it with the COVID-19 test to increase the speed of identifying a predictor in the population.

The growing strategic initiatives by the companies are anticipated to boost market growth. For instance, in March 2022, Immucor, Inc. announced to launch a HLA typing software as a supporting product for its HLA typing assay. The software is expected to ease and quicker the NGS analysis process with a cost-saving option for the users.

On the other hand, the increasing number of recipients removed from the waiting list for organ transplantation is likely to affect the usage of HLA typing. The reasons for the removal from the list are deterioration in the patient's condition, patient's death, or recovery from the disease. For instance, from January 2021 to December 2021, 6 patients from Barnes-Jewish Hospital died due to the shortage of organs, while 11 patients' conditions deteriorated.

HLA Typing Market Report Highlights:

  • By product, the reagents consumables segment is projected to establish the fastest growth rate over the forecast period. Since increasing product development by the existing players to expand the usage of HLA typing in various fields of research, such as immunotherapies
  • By application, the diagnosis segment is anticipated to have the fastest growth rate with a larger share in 2022. Owing to the increase in organ transplantations and showcasing evidence of being an important source of information for infectious diseases, hence, propelling market growth
  • By technique, the sequenced-based molecular assay segment is anticipated to have the fastest CAGR between 2023 to 2030. Since, it has the ability to generate clear, phase-resolved HLA typing with a single assay
  • By end-user, the hospitals and transplant centers segment is projected to have a majority of the market share in 2022. This is attributed to the presence of well-equipped facilities for research in developed countries
  • North America has strengthened its regional position in the market with 46.94% of the overall market share. This is attributed to the presence of transplant centers and clinics, along with the existence of key players in the region

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources
    • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 HLA typing Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing number of organs transplants
    • 3.2.2 Technology advancement in testing techniques
    • 3.2.3 Adoption of HLA testing in Pharmacogenetic
  • 3.3 Market Restraint Analysis
    • 3.3.1 Stringent Regulatory Framework
  • 3.4 HLA typing - SWOT Analysis, By Factor (political & legal, economic, and technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 HLA Typing Market: Market Position Analysis, 2022
  • 3.7 COVID-19 Impact Analysis

Chapter 4 HLA Typing Market: Product Estimates & Trend Analysis

  • 4.1 HLA Typing Market: Product Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments market
  • 4.3 Reagents & consumables
    • 4.3.1 Reagents & consumables market
  • 4.4 Software & Services
    • 4.4.1 Software & services market

Chapter 5 HLA Typing Market: Application Estimates & Trend Analysis

  • 5.1 HLA Typing Market: Application Movement Analysis
  • 5.2 Diagnosis
    • 5.2.1 Diagnosis market
  • 5.3 Research
    • 5.3.1 Research market

Chapter 6 HLA Typing Market: Technique Estimates & Trend Analysis

  • 6.1 HLA Typing Market: Technique Movement Analysis
  • 6.2 Molecular Assay
    • 6.2.1 Molecular assay market
  • 6.3 Sequenced-based Molecular Assay
    • 6.3.1 Sequenced-based molecular assay market
  • 6.4 Non-Molecular Assay
    • 6.4.1 Non-molecular assay Market

Chapter 7 HLA Typing Market: End-user Estimates & Trend Analysis

  • 7.1 HLA Typing Market: End-user Movement Analysis
  • 7.2 Commercial Service Providers
    • 7.2.1 Commercial service providers market
  • 7.3 Hospitals and Transplant Centers
    • 7.3.1 Hospitals and transplant centers market
  • 7.4 Research Labs & Academic Institutes
    • 7.4.1 Research labs & academic institutes market

Chapter 8 HLA typing Market: Regional Estimates & Trend Analysis, by Product, Application, Technique, End-use

  • 8.1 HLA typing Market Share By Region, 2022 & 2030
  • 8.2 North America
    • 8.2.1 SWOT Analysis
      • 8.2.1.1 North America HLA typing market, by product
      • 8.2.1.2 North America HLA typing market, by application
      • 8.2.1.3 North America HLA typing market, by End-user
      • 8.2.1.4 North America HLA typing market, by technique
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 Target Disease Prevalence
      • 8.2.2.3 Competitive Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
      • 8.2.2.6 U.S. HLA typing market, by product
      • 8.2.2.7 U.S. HLA typing market, by application
      • 8.2.2.8 U.S. HLA typing market, by End-user
      • 8.2.2.9 U.S. HLA typing market, by technique
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Target Disease Prevalence
      • 8.2.3.3 Competitive Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
      • 8.2.3.6 Canada HLA typing market, by product
      • 8.2.3.7 Canada HLA typing market, by application
      • 8.2.3.8 Canada HLA typing market, by End-user
      • 8.2.3.9 Canada HLA typing market, by technique
  • 8.3 Europe
    • 8.3.1 SWOT Analysis
      • 8.3.1.1 Europe HLA typing market, by product
      • 8.3.1.2 Europe HLA typing market, by application
      • 8.3.1.3 Europe HLA typing market, by End-user
      • 8.3.1.4 Europe HLA typing market, by technique
    • 8.3.2 Germany
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Target Disease Prevalence
      • 8.3.2.3 Competitive Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
      • 8.3.2.6 Germany HLA typing market, by product
      • 8.3.2.7 Germany HLA typing market, by application
      • 8.3.2.8 Germany HLA typing market, by End-user
      • 8.3.2.9 Germany HLA typing market, by technique
    • 8.3.3 UK
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Target Disease Prevalence
      • 8.3.3.3 Competitive Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
      • 8.3.3.6 UK HLA typing market, by product
      • 8.3.3.7 UK HLA typing market, by application
      • 8.3.3.8 UK HLA typing market, by End-user
      • 8.3.3.9 UK HLA typing market, by technique
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 Target Disease Prevalence
      • 8.3.4.3 Competitive Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
      • 8.3.4.6 France HLA typing market, by product
      • 8.3.4.7 France HLA typing market, by application
      • 8.3.4.8 France HLA typing market, by End-user
      • 8.3.4.9 France HLA typing market, by technique
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Target Disease Prevalence
      • 8.3.5.3 Competitive Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
      • 8.3.5.6 Italy HLA typing market, by product
      • 8.3.5.7 Italy HLA typing market, by application
      • 8.3.5.8 Italy HLA typing market, by End-user
      • 8.3.5.9 Italy HLA typing market, by technique
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Target Disease Prevalence
      • 8.3.6.3 Competitive Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
      • 8.3.6.6 Spain HLA typing market, by product
      • 8.3.6.7 Spain HLA typing market, by application
      • 8.3.6.8 Spain HLA typing market, by End-user
      • 8.3.6.9 Spain HLA typing market, by technique
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Target Disease Prevalence
      • 8.3.7.3 Competitive Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
      • 8.3.7.6 Denmark HLA typing market, by product
      • 8.3.7.7 Denmark HLA typing market, by application
      • 8.3.7.8 Denmark HLA typing market, by End-user
      • 8.3.7.9 Denmark HLA typing market, by technique
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Target Disease Prevalence
      • 8.3.8.3 Competitive Scenario
      • 8.3.8.4 Regulatory Framework
      • 8.3.8.5 Reimbursement Scenario
      • 8.3.8.6 Sweden HLA typing market, by product
      • 8.3.8.7 Sweden HLA typing market, by application
      • 8.3.8.8 Sweden HLA typing market, by End-user
      • 8.3.8.9 Sweden HLA typing market, by technique
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Target Disease Prevalence
      • 8.3.9.3 Competitive Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
      • 8.3.9.6 Norway HLA typing market, by product
      • 8.3.9.7 Norway HLA typing market, by application
      • 8.3.9.8 Norway HLA typing market, by End-user
      • 8.3.9.9 Norway HLA typing market, by technique
  • 8.4 Asia Pacific
    • 8.4.1 SWOT Analysis
      • 8.4.1.1 Asia Pacific HLA typing market, by product
      • 8.4.1.2 Asia Pacific HLA typing market, by application
      • 8.4.1.3 Asia Pacific HLA typing market, by End-user
      • 8.4.1.4 Asia Pacific HLA typing market, by technique
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Target Disease Prevalence
      • 8.4.2.3 Competitive Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
      • 8.4.2.6 Japan HLA typing market, by product
      • 8.4.2.7 Japan HLA typing market, by application
      • 8.4.2.8 Japan HLA typing market, by End-user
      • 8.4.2.9 Japan HLA typing market, by technique
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 Target Disease Prevalence
      • 8.4.3.3 Competitive Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
      • 8.4.3.6 China HLA typing market, by product
      • 8.4.3.7 China HLA typing market, by application
      • 8.4.3.8 China HLA typing market, by End-user
      • 8.4.3.9 China HLA typing market, by technique
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 Target Disease Prevalence
      • 8.4.4.3 Competitive Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
      • 8.4.4.6 India HLA typing market, by product
      • 8.4.4.7 India HLA typing market, by application
      • 8.4.4.8 India HLA typing market, by End-user
      • 8.4.4.9 India HLA typing market, by technique
    • 8.4.5 South Korea
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Target Disease Prevalence
      • 8.4.5.3 Competitive Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
      • 8.4.5.6 South Korea HLA typing market, by product
      • 8.4.5.7 South Korea HLA typing market, by application
      • 8.4.5.8 South Korea HLA typing market, by End-user
      • 8.4.5.9 South Korea HLA typing market, by technique
    • 8.4.6 Australia
      • 8.3.9.1 Key Country Dynamics
      • 8.4.6.2 Target Disease Prevalence
      • 8.4.6.3 Competitive Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
      • 8.4.6.6 Australia HLA typing market, by product
      • 8.4.6.7 Australia HLA typing market, by application
      • 8.4.6.8 Australia HLA typing market, by End-user
      • 8.4.6.9 Australia HLA typing market, by technique
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Target Disease Prevalence
      • 8.4.7.3 Competitive Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
      • 8.4.7.6 Thailand HLA typing market, by product
      • 8.4.7.7 Thailand HLA typing market, by application
      • 8.4.7.8 Thailand HLA typing market, by End-user
      • 8.4.7.9 Thailand HLA typing market, by technique
  • 8.5 Latin America
    • 8.5.1 SWOT Analysis
      • 8.5.1.1 Latin America HLA typing market, by product
      • 8.5.1.2 Latin America HLA typing market, by application
      • 8.5.1.3 Latin America HLA typing market, by End-user
      • 8.5.1.4 Latin America HLA typing market, by technique
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Target Disease Prevalence
      • 8.5.2.3 Competitive Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
      • 8.5.2.6 Brazil HLA typing market, by product
      • 8.5.2.7 Brazil HLA typing market, by application
      • 8.5.2.8 Brazil HLA typing market, by End-user
      • 8.5.2.9 Brazil HLA typing market, by technique
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Target Disease Prevalence
      • 8.5.3.3 Competitive Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
      • 8.5.3.6 Mexico HLA typing market, by product
      • 8.5.3.7 Mexico HLA typing market, by application
      • 8.5.3.8 Mexico HLA typing market, by End-user
      • 8.5.3.9 Mexico HLA typing market, by technique
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Target Disease Prevalence
      • 8.5.4.3 Competitive Scenario
      • 8.5.4.4 Regulatory Framework
      • 8.5.4.5 Reimbursement Scenario
      • 8.5.4.6 Argentina HLA typing market, by product
      • 8.5.4.7 Argentina HLA typing market, by application
      • 8.5.4.8 Argentina HLA typing market, by End-user
      • 8.5.4.9 Argentina HLA typing market, by technique
  • 8.6 MEA
    • 8.6.1 SWOT Analysis
      • 8.6.1.1 MEA HLA typing market, by product
      • 8.6.1.2 MEA HLA typing market, by application
      • 8.6.1.3 MEA HLA typing market, by End-user
      • 8.6.1.4 MEA HLA typing market, by technique
    • 8.6.2 South Africa
      • 8.6.4.1 Key Country Dynamics
      • 8.6.2.2 Target Disease Prevalence
      • 8.6.2.3 Competitive Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
      • 8.6.2.6 Argentina HLA typing market, by product
      • 8.6.2.7 Argentina HLA typing market, by application
      • 8.6.2.8 Argentina HLA typing market, by End-user
      • 8.6.2.9 Argentina HLA typing market, by technique
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Target Disease Prevalence
      • 8.6.3.3 Competitive Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
      • 8.6.3.6 Saudi Arabia HLA typing market, by product
      • 8.6.3.7 Saudi Arabia HLA typing market, by application
      • 8.6.3.8 Saudi Arabia HLA typing market, by End-user
      • 8.6.3.9 Saudi Arabia HLA typing market, by technique
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Target Disease Prevalence
      • 8.6.4.3 Competitive Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
      • 8.6.4.6 UAE HLA typing market, by product
      • 8.6.4.7 UAE HLA typing market, by application
      • 8.6.4.8 UAE HLA typing market, by End-user
      • 8.6.4.9 UAE HLA typing market, by technique
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Target Disease Prevalence
      • 8.6.5.3 Competitive Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
      • 8.6.5.6 Kuwait HLA typing market, by product
      • 8.6.5.7 Kuwait HLA typing market, by application
      • 8.6.5.8 Kuwait HLA typing market, by End-user
      • 8.6.5.9 Kuwait HLA typing market, by technique

Chapter 9 Competitive Landscape

  • 9.1 Participant's overview
  • 9.2 Financial performance
  • 9.3 Participant categorization
    • 9.3.1 Market leaders
      • 9.3.1.1 HLA typing market share analysis, 2022
      • 9.3.1.2 Company profiles
      • 9.3.1.2.1 Thermo Fisher Scientific Inc.
      • 9.3.1.2.2 Bio-Rad Laboratories Inc.
      • 9.3.1.2.3 Qiagen N.V.
      • 9.3.1.2.4 Omixon Inc.
      • 9.3.1.2.5 GenDx
      • 9.3.1.2.6 Illumina Inc.
      • 9.3.1.2.7 TBG Diagnostics Limited
      • 9.3.1.2.8 Dickinson and Company
      • 9.3.1.2.9 Takara Bio Inc.
      • 9.3.1.2.10 F. Hoffman-La Roche Limited
      • 9.3.1.2.11 Pacific Biosciences
    • 9.3.2 Strategy mapping
      • 9.3.2.1 Expansion
      • 9.3.2.2 Acquisition
      • 9.3.2.3 Collaborations
      • 9.3.2.4 Product/service launch
      • 9.3.2.5 Partnerships
      • 9.3.2.6 Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 6 Global HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 7 Global HLA typing Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 12 North America HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 13 U.S. HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 16 U.S. HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 17 Canada HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 20 Canada HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 21 Europe HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Europe HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Europe HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 25 Europe HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 26 Germany HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Germany HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 29 Germany HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 30 U.K. HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 U.K. HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 U.K. HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 33 U.K. HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 34 France HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 France HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 France HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 37 France HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 38 Italy HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Italy HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 41 Italy HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 42 Spain HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Spain HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Spain HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 45 Spain HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 46 Denmark HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Denmark HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 49 Denmark HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 50 Sweden HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Sweden HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 53 Sweden HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 54 Norway HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Norway HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Norway HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 57 Norway HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 63 China HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 China HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 China HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 66 China HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 67 Japan HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Japan HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Japan HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 70 Japan HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 71 India HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 India HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 India HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 74 India HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 75 South Korea HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 South Korea HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 South Korea HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 78 South Korea HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 79 Australia HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 Australia HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Australia HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 82 Australia HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 83 Thailand HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Thailand HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Thailand HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 86 Thailand HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 87 Latin America HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Latin America HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 91 Latin America HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 92 Brazil HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Brazil HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 95 Brazil HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 96 Mexico HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Mexico HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Mexico HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 99 Mexico HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 100 Argentina HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 103 Argentina HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa HLA typing Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 109 South Africa HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 112 South Africa HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 117 UAE HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 120 UAE HLA typing Market, End-user, 2018 - 2030 (USD Million)
  • Table 121 Kuwait HLA typing Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait HLA typing Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait HLA typing Market, by Technique, 2018 - 2030 (USD Million)
  • Table 124 Kuwait HLA typing Market, End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 HLA typing Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 16 Global HLA typing Market: Product Movement Analysis
  • Fig. 17 Global HLA typing Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global HLA typing Market, for Reagents & Consumables, 2018 - 2030 (USD Million)
  • Fig. 19 Global HLA typing Market, for Software & Services, 2018 - 2030 (USD Million)
  • Fig. 20 Global HLA typing Market: Application Movement Analysis
  • Fig. 21 Global HLA typing Market, for Diagnosis, 2018 - 2030 (USD Million)
  • Fig. 22 Global HLA typing Market, for Research, 2018 - 2030 (USD Million)
  • Fig. 23 Global HLA typing Market: Technique Movement Analysis
  • Fig. 24 Global HLA typing Market, for Molecular Assay, 2018 - 2030 (USD Million)
  • Fig. 25 Global HLA typing Market, for Sequenced-based Molecular Assay, 2018 - 2030 (USD Million)
  • Fig. 26 Global HLA typing Market, for Non-Molecular Assay, 2018 - 2030 (USD Million)
  • Fig. 27 Global HLA typing Market: End Use Movement Analysis
  • Fig. 28 Global HLA typing Market, for Commercial Service Providers, 2018 - 2030 (USD Million)
  • Fig. 29 Global HLA typing Market, for Hospitals and Transplant Centers, 2018 - 2030 (USD Million)
  • Fig. 30 Global HLA typing Market, for Research Labs & Academic Institutes, 2018 - 2030 (USD Million)
  • Fig. 31 Regional Marketplace: Key Takeaways
  • Fig. 32 Regional Outlook, 2022 & 2030
  • Fig. 33 Global HLA typing Market: Region Movement Analysis
  • Fig. 34 North America HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.K. HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 40 France HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 48 China HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 49 India HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE HLA typing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait HLA typing Market, 2018 - 2030 (USD Million)